Publication | Open Access

All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding

Ash-rhogap DomainsPatient MutationsSignal TransductionSignaling PathwayReceptor Tyrosine KinasePathologyAppl1 BindingCancer GeneticsMedicineCell BiologyCell Signaling